Contact
Score Calculators

Articles

Book chapters

Clinical practice guidelines

Editorials

Position papers

Protocols

Reviews

AbstractsPublication policy

Abstracts

Showing 10 of 76 abstracts

Need for a different definition of SIRS and occult sepsis – In cirrhosis, without cirrhosis and ACLF?

Moreau R.

APASL Single Topic Conference, Asian Pacific Association for the Study of the Liver (APASL), 14 December 2025, Yangon, Myanmar.

Management of infection and sepsis in cirrhosis

Moreau R.

APASL Single Topic Conference, Asian Pacific Association for the Study of the Liver (APASL), 13 December 2025, Yangon, Myanmar.

Evidence for nonetiological treatments of cirrhosis

Moreau R.

HEPATO 2025 – XXIX Congresso Brasileiro de Hepatologia, 10 October 2025, Rio de Janeiro, Brazil.

Lessons from ACLARA study

Moreau R.

HEPATO 2025 – XXIX Congresso Brasileiro de Hepatologia, 9 October 2025, Rio de Janeiro, Brazil.

EF CLIF view on translational research

Moreau R.

Grifols Chair Symposium: Translating Science into the Clinics, European Association for the Study of Chronic Liver Failure (EF CLIF), Barcelona, Spain, 25 March 2025.

EF CLIF: A European network of research on cirrhosis

Moreau R.

Indo-French Node "Liver and Metabolic Disease Network" (InFLiMeN) Seminar, Centre Franco-Indien pour la Promotion de la Recherche Avancée (CEFIPRA) and Indo-French Centre for the Promotion of Advanced Research (IFCPAR), Paris, France, 28 January 2025.

The lipid mediator landscape associated with infection and organ failure in patients with advanced liver disease

Romero-Grimaldo B, de la Peña-Ramirez C, Duran-Güell M, Contreras BJ, Sánchez-Rodríguez MB, Aguilar F, Clària J, López-Vicario C.

9th European Workshop on Lipid Mediators (9EWLM), 26–28 June 2024, Edinburgh, UK.

The linoleic acid-derived leukotoxin 9,10-diHOME drives immunosuppression in patients with acute-on-chronic liver failure

Contreras BJ, López-Vicario C, Casulleras M, Duran-Güell M, Romero-Grimaldo B, Trebicka J, Clària J.

9th European Workshop on Lipid Mediators (9EWLM), 26–28 June 2024, Edinburgh, UK.

Albumin reprograms the B cell transcriptional landscape and rescues neutrophil dysfunction in immunocompromised patients with advanced cirrhosis

Clària J, Aguilar F, Lozano JJ, Jiménez-Gracia L, Nieto JC, Romero-Grimaldo B, Marcos-Fa X, Giarracco E, Weiss E, Trebicka J, Hernàndez I, Fernandez J, Casulleras M, López-Vicario C, Muldur S, Hopke A, Vlagea A, Aransay AM, Marchese D, Bernardi M, Jalan R, Angeli P, Magri G, Cerutti A, Irimia D, Heyn H, Arroyo V, Moreau R.

The Liver Meeting 2024, American Association for the Study of Liver Diseases (AASLD), 15–19 November 2024, San Diego, CA, USA.

Intravenous administration with the ASK1 inhibitor SRT-015 alleviates liver injury and systemic inflammation in disease models of liver failure

Legry V, Malysiak M, Poulain P, Daix V, Hanf R, Hum D, Staels B, Clària J, Sayah-Jeanne S.

The Liver Meeting 2024, American Association for the Study of Liver Diseases (AASLD), 15–19 November 2024, San Diego, CA, USA.

Registered office

European Foundation for the Study of
Chronic Liver Failure
Avinguda Diagonal 477, 11th floor
08036 Barcelona, Spain

Legal

Contact us

Tel: +34 93 227 14 00
Email: Send us an email

© 2025 European Foundation for the Study of Chronic Liver Failure